Programme

Programme Highlightsbrochures
Last Updated : 25th July 2016
  • What do we do in complete responses post neoadjuvant chemoradiotherapy in rectal cancers?
    Dr Mark Saunders FRCR PhD, Consultant Clinical Oncologist, The Christie NHS Trust, Manchester, UK
  • Carbon Ion Radiotherapywill be awarded
    Prof Naruhiro Matsufuji PhD, QST-National Institute of Radiological Sciences, Japan
  • Radiotherapy Dosimetry
    Prof David Bradley, PhD,  University of Surrey, UK
  • Breast surgery post neoadjuvant treatment : Mastectomy or Breast Conserving surgery?
    Prof Dato’ Yip Cheng Har FRCS,  Consultant Breast Surgeon, Sime Darby Medical Centre, Kuala Lumpur, Malaysia
  • CROSS Trial and beyond : The hallmarks of multimodality therapy in oesophageal cancer
    Dr Tom Richards FRCR PhD, Consultant Clinical Oncologist, Barts Health NHS Trust, London, UKaradiationprotection
  • Experiences in Stereotactic Ablative Body Radiotherapy (SABR) in Non Small Cell Lung Cancer : An Alternative to Surgery 
    Dr Jeremy Ruben FRANZCR, Consultant Radiation Oncologist, William Buckland Radiotherapy Centre, Melbourne, Australia
  • Concurrent chemoradiotherapy followed by surgery in Pancoast’s tumour : An example of multimodality therapy
    Dr Francis Ho Cho Hao FRANZCR, Consultant Radiation Oncologist, National University Cancer Institute, Singapore
  • Advances in Radiotherapy Treatment Planning
    Dr Supriyanto A. Pawiro PhD, Department of Physics, FMIPA, Universitas Indonesia
  • Optimising treatment in potentially resectable liver metastasis in colorectal cancer
    Assoc Prof Dato’ Dr Fuad Ismail FFRRCS FRCR, Consultant Clinical Oncologist, Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur.
  • Cyberknife and Challenging Lesions
    Dato’ Dr Ibrahim Wahid, Consultant Clinical Oncologist, Beacon Specialist Hospital, Kuala Lumpur, Malaysia
  • Surgery post neoadjuvant therapy in rectal cancers : The challenges
    Prof Mr Ismail Sagap, Consultant Colorectal Surgeon, Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur. 
  • Role of immunotherapy in multimodality treatments
    Dr Tho Lye Mun FRCR PhD, Consultant Clinical Oncologist, Beacon Specialist Centre, Kuala Lumpur, Malaysia
  • Oesophagectomy post neoadjuvant therapy
    Mr Mohamad Shukri Jahit, Consultant Upper GI Surgeon, Hospital Sungai Buloh
  • Role of palliative nephrectomy in the era of systemic tyrosine kinase inhibitors.
    Dr A Radzi, CEO & Consultant Clinical Oncologist, Integrated Oncology Centre, Johor Bahru, Malaysia 
  • How radical can and should we go in head and neck surgery?
    Dr Zulkifli Yusof, Consultant ENT Surgeon and Head of Department, Hospital Sultanah Bahiyah, Alor Setar, Malaysia
  • How p16 influences radiotherapy decisions in Oropharyngeal Cancers?
    Dr Beng Yap, Consultant Clinical Oncologist, Sime Darby Medical Centre, Kuala Lumpur, Malaysia
  • Image Guided Radiotherapy (IGRT) in Head and Neck Cancers
    Dr Hafiz Mohd Zin, Senior Lecturer/Medical Physicist, AMDI, Universiti Sains Malaysia
  • and many more

Comments are closed